DeepMed Research

Dinalbuphine sebacate

Generic Name: Dinalbuphine sebacate

Drug Type: Small Molecule

Chemical Formula: C_₅₂H_₆₈N_₂O_₁₀

CAS Number: 311768-81-7

Unique Ingredient Identifier: 464OXX39Y6

Background: Dinalbuphine sebacate is under investigation in clinical trial NCT02468128 (A Study of Intramuscular Sebacoyl Dinalbuphine Ester for Post-Hemorrhoidectomy Pain Management).

Clinical Trials

The Efficacy and Safety of NALDEBAIN for the Treatment of Post-Laparotomy Surgery

Phase 4

Conditions: Pain, Postoperative

Interventions: Drug: Fentanyl Citrate
Drug: Nalbuphine Sebacate

First Posted Date: 2017-09-28

Last Posted Date: 2017-09-28

Lead Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital

Target Recruit Count: 110

Registration Number: NCT03296488

Locations: 🇨🇳
Chung-Ho Memorial Hospital, Kaohsiung Medical University:, Kaohsiung, Taiwan

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy